Literature DB >> 2360516

Mechanism of abnormal postexercise systolic blood pressure response and its diagnostic value in patients with coronary artery disease.

T Miyahara1, M Yokota, M Iwase, M Watanabe, T Matsunami, M Koide, H Saito, J Takeuchi.   

Abstract

To define the factors that affect an abnormal postexercise systolic blood pressure (SBP) response and to verify the diagnostic value of that response in patients with coronary artery disease (CAD), we studied 33 normal subjects, eight patients with hypertension who had no CAD, and 42 patients with documented CAD who underwent supine leg exercise testing. SBP recovery ratios were derived by dividing the values obtained 1 and 3 minutes after exercise by the peak value. The upper normal limit of the SBP ratio was defined by two standard deviations from the mean for 33 normal subjects. The specificity of this criterion for identifying patients with CAD was 97% and the sensitivity was 60%. None of the eight patients with hypertension showed an abnormal postexercise SBP response. At peak exercise the pulmonary artery wedge pressure was significantly greater in the patients with CAD having an abnormal response. In multiple regression analysis the exercise pulmonary artery wedge pressure, the exercise SBP, and the systemic vascular resistance after exercise were determining factors for an abnormal SBP response. Three-vessel disease was more common in patients with an abnormal response. Results of this study indicate that an abnormal postexercise SBP response appears to be determined by (1) the extent of exercise-induced impairment of left ventricular function and (2) peripheral vascular tone during recovery. This study also suggests that this criterion can increase the specificity of supine exercise testing in patients with CAD including those with hypertension and might provide a marker for the severity of impaired left ventricular function by exercise in CAD.

Entities:  

Mesh:

Year:  1990        PMID: 2360516     DOI: 10.1016/0002-8703(90)90158-t

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Influence of age on blood pressure recovery after maximal effort ergometer exercise in non-athletic adult males.

Authors:  Uchechukwu Dimkpa; A C Ugwu
Journal:  Eur J Appl Physiol       Date:  2009-05-22       Impact factor: 3.078

2.  Autonomic neural control of the cardiovascular system in patients with Behçet's disease in the absence of neurological involvement.

Authors:  Tansel Erol; Abdullah Tekin; Müge Tufan; Hakan Altay; Göknur Tekin; Muhammet Bilgi; Bülent Özin; Eftal Yücel; Haldun Müderrisoğlu
Journal:  Clin Rheumatol       Date:  2012-07-25       Impact factor: 2.980

3.  Impaired systolic blood pressure recovery and heart rate recovery after graded exercise in patients with metabolic syndrome.

Authors:  Yusuf I Alihanoglu; Bekir S Yildiz; I Dogu Kilic; Burcu Uludag; Emre E Demirci; Mustafa Zungur; Harun Evrengul; Asuman H Kaftan
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

4.  The interplay of exercise heart rate and blood pressure as a predictor of coronary artery disease and arterial hypertension.

Authors:  Andreas P Michaelides; Charalampos I Liakos; Gregory P Vyssoulis; Evangelos I Chatzistamatiou; Maria I Markou; Vanessa Tzamou; Christodoulos I Stefanadis
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-11-26       Impact factor: 3.738

5.  South Asians have elevated postexercise blood pressure and myocardial oxygen consumption compared to Europeans despite equivalent resting pressure.

Authors:  Nish Chaturvedi; Rajaram Bathula; Angela C Shore; Ronney Panerai; John Potter; Jaspal Kooner; John Chambers; Alun D Hughes
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

6.  Deteriorated Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Children With Familial Mediterranean Fever.

Authors:  Havva Evrengül; Selçuk Yüksel; Mustafa Doğan; Dolunay Gürses; Harun Evrengül
Journal:  Arch Rheumatol       Date:  2017-04-05       Impact factor: 1.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.